Virologic and immunologic response to HAART, by age and regimen class - Wikidata - awgldk - TriplyDB

Virologic and immunologic response to HAART, by age and regimen class

Virologic and immunologic response to HAART, by age and regimen class

http://www.wikidata.org/entity/Q34137148

about

Management of HIV/AIDS in older patients-drug/drug interactions and adherence to antiretroviral therapy HIV and Menopause: A Systematic Review of the Effects of HIV Infection on Age at Menopause and the Effects of Menopause on Response to Antiretroviral Therapy HIV infection and older Americans: the public health perspective A Review of Management of Inflammation in the HIV Population Absence of effect of menopause status at initiation of first-line antiretroviral therapy on immunologic or virologic responses: a cohort study from Rio de Janeiro, Brazil Impact of defined clinical population and missing data on temporal trends in HIV viral load estimation within a health care system.CD4+ cells recovery in HIV positive patients with severe immunosuppression at HAART initiation at Centre Medico-Social Cor-Unum, Kigali Validation of Medicaid Claims-based Diagnosis of Myocardial Infarction Using an HIV Clinical Cohort Prevalence and risk factors of poor immune recovery among adult HIV patients attending care and treatment centre in northwestern Tanzania following the use of highly active antiretroviral therapy: a retrospective study.Antiretroviral therapy initiation within seven days of enrolment: outcomes and time to undetectable viral load among children at an urban HIV clinic in Uganda.Clinical predictors of immune reconstitution following combination antiretroviral therapy in patients from the Australian HIV Observational Database.Age at antiretroviral therapy initiation predicts immune recovery, death, and loss to follow-up among HIV-infected adults in urban Zambia.Sex, age, race and intervention type in clinical studies of HIV cure: a systematic review.Trends of CD4 cell count levels at the initiation of antiretroviral therapy over time and factors associated with late initiation of antiretroviral therapy among Asian HIV-positive patients.Delay in cART initiation results in persistent immune dysregulation and poor recovery of T-cell phenotype despite a decade of successful HIV suppression.Using the pathogenic and nonpathogenic nonhuman primate model for studying non-AIDS comorbidities.Discontinuing Pneumocystis jirovecii Pneumonia Prophylaxis in HIV-Infected Patients With a CD4 Cell Count <200 cells/mm3.Full Viral Suppression, Low-Level Viremia, and Quantifiable Plasma HIV-RNA at the End of Pregnancy in HIV-Infected Women on Antiretroviral Treatment HIV RNA suppression and immune restoration: can we do better?The Factors Related to CD4+ T-Cell Recovery and Viral Suppression in Patients Who Have Low CD4+ T Cell Counts at the Initiation of HAART: A Retrospective Study of the National HIV Treatment Sub-Database of Zhejiang Province, China, 2014.Temporal trends in the discontinuation of first-line antiretroviral therapy Influence of provider experience on antiretroviral adherence and viral suppression.Comparing longitudinal CD4 responses to cART among non-perinatally HIV-infected youth versus adults: Results from the HIVRN Cohort.Outcomes of second combination antiretroviral therapy regimens among HIV-infected persons in clinical care: a multicenter cohort study.Early diagnosis and treatment of HIV infection: magnitude of benefit on short-term mortality is greatest in older adults Management of human immunodeficiency virus infection in advanced age.Effect of age on immunological response in the first year of antiretroviral therapy in HIV-1-infected adults in West Africa.Validation of an algorithm to identify antiretroviral-naïve status at time of entry into a large, observational cohort of HIV-infected patients [Risk factors associated with virologic failure in HIV- infected patients receiving antiretroviral therapy at a public hospital in Peru].Growing Old with HIV.Evidence informing the intersection of HIV, aging and health: a scoping review.Antiretroviral Treatment Efficacy and Safety in Older HIV-Infected Adults.Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.The role of SNPs in the α-chain of the IL-7R gene in CD4+ T-cell recovery in HIV-infected African patients receiving suppressive cART.Adherence to combination antiretroviral treatment and clinical outcomes in a Medicaid sample of older HIV-infected adults.Immunosenescence and hurdles in the clinical management of older HIV-patients.Predictors of immune recovery and the association with late mortality while on antiretroviral treatment in Cambodia.Weight Gain and Incident Diabetes Among HIV-Infected Veterans Initiating Antiretroviral Therapy Compared With Uninfected Individuals.Effectiveness of first-line antiretroviral therapy in HIV/AIDS patients: A 5-year longitudinal evaluation in Fujian Province, Southeast China.Increased costs of HIV care associated with aging in an HIV-infected population.

P2860

Q26775832-C34851CD-DDEC-47C8-ADD1-5B94FCFA97F5 Q26852180-75E82C5A-E32E-4AEE-82AD-C3A39D90C20F Q26858824-D3CA91B7-D55C-4A3E-89FE-65F881ADFB65 Q28078962-7E348F13-A468-45F9-8455-16702E6E318A Q28540014-249B3B4F-69BB-473D-AFEC-A37C8D312D55 Q30894245-658BFFCA-1748-4CA9-B0A9-D2586FF44FE4 Q33583499-32E4A4A8-7EA4-4BF3-8FD3-490A1170A535 Q33618727-A1462249-DC82-4FE1-A9B3-FE770678A62D Q33781469-0652C633-C2BD-46CF-A169-49A272885B9E Q33814363-9FBAE072-87DA-4D9F-9D12-F2F0F1AD7CED Q33933071-0DD42CA5-92DC-48DF-8898-B0E701446E55 Q34266281-B5B1EB2C-EE85-45D7-8E9A-D7257FB0298B Q34870233-47E97EB4-B564-425A-88CB-31A0F60559B5 Q35111937-485A7776-34F9-41EF-876C-DF6F70F1B798 Q35141793-373443E1-9317-48FA-97CB-6840BF6056F9 Q35204909-2E4B23FC-3954-48B4-B9EC-37680E7D8651 Q35769862-BD4DB944-A226-4943-B47E-3BAB0800D84E Q35861475-5B4DEEE0-7D53-4532-B832-98177FC64948 Q35867173-3914B494-3BBF-413F-8F5B-FA7ADFC15CBA Q35930384-2EA057FF-524B-476B-A3C2-E3257E9A5730 Q36093602-860DE1F4-95F0-4404-8D75-75C3AAA190F0 Q36177542-975CA36A-A992-4508-811B-D4E37E9B5BA8 Q36275359-B8FEFD2E-7DE2-4030-B6D6-4CF631FA07E8 Q36634843-F7725EB8-8F83-407C-824D-8242970888EE Q36933509-90424853-B784-40BD-B003-88BD896837D4 Q36933984-066C1ED8-F9C9-4FA8-B767-EB60B223BDA5 Q36992075-022575D2-70EC-40F5-9F8B-EC3834AFE94B Q37318637-C3C762DA-2A52-4FD1-B887-03682451B7C9 Q37481106-4B901595-C9D2-4D8A-8F4C-980502139CA1 Q37838796-94D77EAF-47FE-467A-A475-B6C5A5B5BF83 Q38159448-CB72F7EC-A083-4E46-8C27-9E818CE54AF7 Q38673884-276A7C02-77DC-4D22-B9EC-F65D2C924C39 Q38861593-6097D260-B9C0-482A-A5FA-324CBBAE05EE Q38869327-F0E9E504-EA88-43CE-8943-813717FC3C8C Q39148090-5B1D5D4C-212A-4344-AA3D-EC453E228C52 Q39170367-7BFB4C0D-FC0F-492B-A10E-30F01B87E68A Q39550582-6EFA763D-37EE-40E4-AF22-DCABEE76B4C0 Q39772256-2E4CDDE1-F1BA-4A37-9064-09E4CB13693C Q41020993-0AA85B46-0F95-4087-AAF6-D023C53A5ADB Q42202635-A209E110-A386-4873-81DF-9F1B57BBB7A7

P2860

Virologic and immunologic response to HAART, by age and regimen class

http://www.wikidata.org/entity/Q34137148

description

2010 nî lūn-bûn

@nan

2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Virologic and immunologic response to HAART, by age and regimen class

@ast

Virologic and immunologic response to HAART, by age and regimen class

@en

Virologic and immunologic response to HAART, by age and regimen class

@nl

type

label

Virologic and immunologic response to HAART, by age and regimen class

@ast

Virologic and immunologic response to HAART, by age and regimen class

@en

Virologic and immunologic response to HAART, by age and regimen class

@nl

prefLabel

Virologic and immunologic response to HAART, by age and regimen class

@ast

Virologic and immunologic response to HAART, by age and regimen class

@en

Virologic and immunologic response to HAART, by age and regimen class

@nl

P1433

Q34137148-C4262B55-B078-4C2F-975F-91EE93535BD3

P1476

Q34137148-2242A605-091F-41EA-862E-5D31CE3F5D30

P2093

Q34137148-0FAE4E1B-478B-48AB-BB35-B40DC5192521

Q34137148-190C2A53-7D03-45E2-91B8-5F846ABF7009

Q34137148-3770FFB2-34C7-420D-B220-8675338901D7

Q34137148-533A756B-A533-4A75-AD92-0AEBADCD6779

Q34137148-57FA936F-30F8-4CA0-8905-F7F52A1BF446

Q34137148-71743717-4185-485B-979F-B31ACFF7A8D2

Q34137148-8A283807-7ED9-4DE4-8BA8-7C29B2A1E152

Q34137148-C42E34D8-4E84-4FD9-A171-DCDE722B43CB

Q34137148-DD3BB843-D96F-49F8-935D-3D1EA8F750E0

P2860

Q34137148-030E1346-EC31-41F6-A3CC-8FB18BA441D8

Q34137148-03C0222D-6D11-40F7-A3A6-039F1F74733A

Q34137148-0FAF4329-993A-4A1C-9271-691B54AF61CE

Q34137148-2DA2CCDC-DB3F-4A23-AC98-6C1EF50E7FB8

Q34137148-3637A05F-0BB7-4163-8E8D-918FD3C22ACC

Q34137148-3BB728BC-26C7-42A4-95B2-3C36304AE545

Q34137148-3D331E49-71DD-4802-B252-54F256CC132A

Q34137148-41B997B0-6AB2-4A8E-A3C4-6131FCECEDF5

Q34137148-45A28819-AD0C-4C70-A4FA-0FA444323A2A

Q34137148-949AD32E-9ECC-4111-84F5-3D301AF67898

P304

Q34137148-8FB57C0A-E089-4D9D-8A0F-92C5FBCFEFF8

P31

Q34137148-6CCCC5D0-F06C-40CE-9931-20FDC4256D44

P356

Q34137148-2BE40565-11A9-4119-9E65-C6D7149DBEF6

P407

Q34137148-D4BD115C-D9CB-49C2-900B-338DC283CE83

P433

Q34137148-A8734ACB-70E2-4862-859A-7E9EE2F4F0A6

P478

Q34137148-E0D29DE3-3D2D-4BFA-865F-6B210A9058AE

P50

Q34137148-5F8ED67A-B74D-4817-A0D9-AA8535B25294

Q34137148-69CF9BE1-DF81-49B5-9FDD-C9A049883C3D

Q34137148-8522FEBF-6037-4A86-B7A8-24290F8A606E

Q34137148-ABBFDB05-50F6-4D3D-B000-797144011561

P577

Q34137148-D9C8AEC4-43E8-4F3B-9A2C-C3446CE0D02D

P5875

Q34137148-04B5DC70-F899-4711-B3E2-F7BEEBCE61B6

P698

Q34137148-AB78C247-72AC-4907-8B90-520F1A83F7E2

P921

Q34137148-EE766EA0-AB84-40FE-849B-D2A1C795F1E2

P932

Q34137148-22844B7E-92B2-4179-88BF-292FB88C1232

P356

QAD.0B013E32833E6D14

P1433

P1476

Virologic and immunologic response to HAART, by age and regimen class

@en

P2093

Amy C Justice

http://www.w3.org/2001/XMLSchema#string

Bryan Lau

http://www.w3.org/2001/XMLSchema#string

Ellen Tedaldi

http://www.w3.org/2001/XMLSchema#string

Kelly A Gebo

http://www.w3.org/2001/XMLSchema#string

Keri N Althoff

http://www.w3.org/2001/XMLSchema#string

Marina B Klein

http://www.w3.org/2001/XMLSchema#string

Michael J Silverberg

http://www.w3.org/2001/XMLSchema#string

Michael S Saag

http://www.w3.org/2001/XMLSchema#string

North American AIDS Cohorts Collaboration on Research, Design (NA-ACCORD)

http://www.w3.org/2001/XMLSchema#string

P2860

Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).

Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse

Comparison of dynamic treatment regimes via inverse probability weighting.

HIV infection in older adults.

Effect of age and HAART regimen on clinical response in an urban cohort of HIV-infected individuals.

Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel.

Class-sparing regimens for initial treatment of HIV-1 infection.

Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged >50 years.

P304

2469-2479

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0B013E32833E6D14

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Michael John Gill

Sonia Napravnik

P577

2010-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46191721

http://www.w3.org/2001/XMLSchema#string

P698

20829678

http://www.w3.org/2001/XMLSchema#string

P921

P932

3136814

http://www.w3.org/2001/XMLSchema#string